BE732141A - - Google Patents

Info

Publication number
BE732141A
BE732141A BE732141A BE732141A BE732141A BE 732141 A BE732141 A BE 732141A BE 732141 A BE732141 A BE 732141A BE 732141 A BE732141 A BE 732141A BE 732141 A BE732141 A BE 732141A
Authority
BE
Belgium
Application number
BE732141A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE732141A publication Critical patent/BE732141A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE732141A 1969-04-24 1969-04-25 BE732141A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21084/69A GB1254057A (en) 1969-04-24 1969-04-24 Improvements in or relating to therapeutical composition containing vincamine

Publications (1)

Publication Number Publication Date
BE732141A true BE732141A (fr) 1969-10-01

Family

ID=10156932

Family Applications (1)

Application Number Title Priority Date Filing Date
BE732141A BE732141A (fr) 1969-04-24 1969-04-25

Country Status (2)

Country Link
BE (1) BE732141A (fr)
GB (1) GB1254057A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392717A1 (fr) * 1989-04-04 1990-10-17 Eli Lilly And Company Formulations pharmaceutiques contenant des immunoconjugués

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392717A1 (fr) * 1989-04-04 1990-10-17 Eli Lilly And Company Formulations pharmaceutiques contenant des immunoconjugués

Also Published As

Publication number Publication date
GB1254057A (en) 1971-11-17

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU450150B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442463B2 (fr)
AU442535B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU442380B2 (fr)
AU442357B2 (fr)
AU442285B2 (fr)
AU470661B1 (fr)
AU4949169A (fr)
CS148870B1 (fr)
CS148418B1 (fr)
AU5397469A (fr)
AU5228269A (fr)
AU4540468A (fr)
AU5109569A (fr)
AU5077469A (fr)
BE732141A (fr)
BE756717A (fr)
AU4982068A (fr)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MESDAMES OLIVIER LOUISETTE & ALBERT ODILE

Effective date: 19890425